|
ALDX Aldeyra Therapeutics Inc 1341235 |
| Balance Sheet |
|
Current Assets
|
104,072,478 |
|
Assets
|
104,606,694 |
|
Current Liabilities
|
18,601,823 |
|
Liabilities
|
33,601,823 |
|
Equity
|
71,004,871 |
|
Shares Out
|
59,422,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-43,208,747 |
|
Investing Cash Flow
|
-44,915,755 |
| Market Analysis |
Market Cap
|
340,485,482 |
|
Price
|
6.76 |
|
BVPS
|
1.19 |
|
PB
|
5.43 |
|
EPS
|
-0.64 |
|
PS
|
2.62 |
|
FCF
|
-88,124,502 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/28 |
-0.94 |
3/07 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALDX documents filed with the SEC.
ALDX Filings
Clear
